Investigation of short- and long-term therapy outcome in treatment of thrombotic microangiopathies – retrospective anonymized data collection.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038795

Enrollment

250

Registered

2025-12-19

Start date

2025-07-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thrombotic microangiopathy (TTP, M31.1

Interventions

Group 1: This retrospective study will include all patients treated at the LMU University Hospital between 2012 and 2025. The course of the disease will then be described under new treatment options (

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with thrombotic microangiopathy who were treated at the LMU University Hospital between 2012 and 2025

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Description of the acute and long-term progression of the disease (type of therapy, duration of hospital treatment, time to response, occurrence of relapse, side effects/complications) and comparison of the different treatment options. The extent of kidney damage in short and long term and therapy-refractory courses is of special interest.	—

Countries

Germany

Contacts

Public ContactUlf Schönermarck

LMU Klinikum, Med. Klinik und Poliklinik IV, Nephrologisches Zentrum

NephroStudien-GH@med.uni-muenchen.de0049 89 4400 72372

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026